Clinical Trial Detail

NCT ID NCT04450732
Title Safety of GQ1001 in Adult Patients With HER2-Positive Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors GeneQuantum Healthcare (Suzhou) Co., Ltd.
Indications

gastroesophageal junction adenocarcinoma

Her2-receptor positive breast cancer

gastric adenocarcinoma

Advanced Solid Tumor

Therapies

GQ1001

Age Groups: senior adult

Additional content available in CKB BOOST